Health6 hours ago
Adaptimmune Therapeutics Moves to Delist from NASDAQ
Adaptimmune Therapeutics has announced its decision to initiate the delisting of its American Depositary Shares (ADS) from The Nasdaq Capital Market. Each ADS represents six ordinary...